#outperform-rating
Latest news and interesting information about outperform-rating.
Wolfe Research Starts Alto Neuroscience with Outperform
Wolfe Research initiates coverage on Alto Neuroscience with an outperform rating and $35 price target. ALTO-207 pipeline highlighted.
...
